The Ministry of Social Affairs has decided to allocate 4.9 million SEK to the innovation project BrAInChild, as part of the larger initiative within Genomic Medicine Sweden (GMS). BrAInChild aims to develop and implement advanced precision diagnostics for children with cancer, potentially leading to more individualized and effective treatments.
A central player in this effort is Barntumörbanken, which plays a crucial role in collecting and analyzing genetic data from children with tumor diseases. By integrating large data sources, such as whole genome sequencing and clinical treatment results, Barntumörbanken contributes to creating a more comprehensive picture of disease progression, enabling improved treatment strategies.
This funding is part of the government's broader investment in precision health, with a total of 80 million SEK allocated to strengthening research and the implementation of precision medicine within Swedish healthcare. BrAInChild is one of several projects receiving support to promote more equitable and advanced care for patients with complex medical conditions.
Facts about Barntumörbanken
Barntumörbanken is a national biobank at Karolinska Institutet, specialized in the collection and analysis of tumor samples from children with cancer. It plays a crucial role in precision medicine, where genetic data is used to tailor treatments and improve survival chances for children with cancer.
Purpose and Function
- Collects, stores, and analyzes tumor tissue and blood samples from children with cancer.
- Conducts advanced genetic analyses, including whole genome sequencing and RNA sequencing.
- Provides data to researchers to enhance diagnostics and treatment of childhood cancer.
Collaborating Partners
- Barncancerfonden funds the operations.
- SciLifeLab supports genomic analyses.
- Stockholm Medical Biobank manages sample collection.
- Collaborates with Sweden's six university hospitals for sample gathering.
